Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

EGF decreases the amount of COPS6. 4 / 4

| 4

➶

reach

"We assessed the ubiquitination of CSN6 in the presence of EGF and found that EGF reduced the ubiquitination level of WT CSN6 but not that of the CSN6 S148A mutant."

26267535

➶

reach

"We assessed the ubiquitination of CSN6 in the presence of EGF and found that EGF reduced the ubiquitination level of WT CSN6 but not that of the CSN6 S148A mutant (XREF_FIG)."

26267535

➶

reach

"Furthermore, we found that EGF treatment or ERK2 activation decreases the ubiquitination level of CSN6 (XREF_FIG)."

26267535

➶

reach

"Furthermore, we found that EGF treatment or ERK2 activation decreases the ubiquitination level of CSN6."

26267535

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

EGF decreases the amount of COPS6. 4 / 4

Our Sources:

Databases

Reading